MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model

Wiktoria Bębenek(University of Łódź), Aneta Rogalska(University of Łódź)
International Journal of Molecular Sciences
January 20, 2025
10.3390/ijms26020834
Cited by 1

Related Papers

Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
|Cells|2023|23
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines
|International Journal of Molecular Sciences|2025|5
Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer
|International Journal of Molecular Sciences|2026|0